Clinical Trial Update: A Combination Therapy In Patients With Social Anxiety Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a combination therapy for social anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Social Phobia | Phase 2 | Status: COMPLETED